Should I Buy A? A 2026 Analysis

Should You Buy Agilent Technologies Inc (A) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

127.060

1 Day change

2.20%

52 Week Range

160.270

Analysis Updated At

2026/06/18

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Agilent Technologies Inc is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The technical indicators are bearish, options sentiment is neutral to slightly bearish, and recent congressional trading shows caution with more selling activity. While analysts have generally positive views with raised price targets, the stock's recent performance and lack of immediate positive catalysts suggest holding off on investment until clearer growth drivers materialize.

Technical Analysis

The MACD is negatively expanding (-1.222), RSI (41.902) is neutral, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key resistance levels, with support at $125.216 and resistance at $131.063. Overall, the technical indicators suggest a bearish trend.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

Analysts have raised price targets recently, with some maintaining Buy ratings. The company has shown solid execution in its latest quarter, with strong product cycles and broad demand strength.

Neutral/Negative Catalysts

Congressional trading shows more selling activity, indicating caution. Technical indicators are bearish, and the stock has a 70% chance of declining in the short term. No recent news or event-driven catalysts to support a positive sentiment.

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are mixed but leaning positive. Recent ratings include Buy and Neutral, with price targets ranging from $130 to $165. Analysts highlight solid execution and growth potential but also note sector headwinds and a preference to wait for clearer growth drivers.

13 Analyst Rating

Wall Street analysts forecast A stock price to rise

12 Buy

1 Hold

0 Sell

Strong Buy

Current: 124.330

Low

160

Averages

171.67

High

180

Current: 124.330

Low

160

Averages

171.67

High

180

Piper Sandler

David Westenberg

Neutral

initiated

$150

AI Analysis

2026-06-11

Reason

Piper Sandler

David Westenberg

Price Target

$150

AI Analysis

2026-06-11

initiated

Neutral

Reason

Piper Sandler analyst David Westenberg initiated coverage of Agilent with a Neutral rating and $150 price target. The firm launched coverage of the life science tools sector with a \"feet in the shallow end of the pool\" approach. Piper only recommends buying Twist Bioscience for its growing exposure to next generation drug discovery and development. Headwinds for the group faces from biotech and academic spending as well as China exposure will likely improve near term, the analyst tells investors in a research note. However, Piper wants to see some of the next big growth drivers materialize before recommending more of the stocks. Investors \"can buy multi-year growth compounding stocks early, middle, and late into their growth cycles but would simply prefer to wait out a couple quarters for the sector to perform like it did pre-Covid,\" the firm contends.

HSBC

Sidharth Sahoo

Buy

downgrade

$180 -> $165

2026-06-03

Reason

HSBC

Sidharth Sahoo

Price Target

$180 -> $165

2026-06-03

downgrade

Buy

Reason

HSBC analyst Sidharth Sahoo lowered the firm's price target on Agilent to $165 from $180 and keeps a Buy rating on the shares. The firm says market expectations on life science tools "remain bearish" with allocation tilted towards managed care and therapeutics within healthcare. While the tools sector is priced for disappointment, HSBC sees "green shoots of recovery," notably in bioprocessing and quality assurance, the analyst tells investors in a research note. The firm adjusted target prices to reflect risk-adjusted return expectations. HSBC's preferred ideas are Waters, Iqvia, and Sartorius.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for A

Unlock Now

A Should I Buy

A Should I Buy

Should You Buy Agilent Technologies Inc (A) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch